AGP Picks
View all

LATAM News Online: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on LATAM News Online.

Press releases published on October 28, 2026

Avalo Unifies Its Brand Across Payments, Treasury and Fintech Banking
Damian Maggio Explains How Investors Can Read Valuation Marks in Late-Stage Private Technology Companies
Horton Releases Spanish-Language Versions of its Full-Line and Healthcare Catalogs
ANTIGUA AND BARBUDA SHOWCASE MICE CAPABILITIES AND TOURISM OFFERINGS AS HOST OF COMMONWEALTH HEADS OF GOVERNMENT MEETING
Where Short Tracks Build Champions, Incubators Build Companies: The Nussbaum Center and The Steelhouse
The Simonetta Lein Show Welcomes Hollywood Star Emmy Nominated Actress Sarah Drew
Freaky Deaky Promo Code 'RSVP' and "NOCTURNALSD' - Last Minute Special Release
Red Frog Beach Advances Major Infrastructure and Sustainability Improvements
'All That' Star Angelique Bates Continues 'Queen of the Red Carpet' Run At Successful RUSH Halloween Party & Screening
Brazilian LegalTech Macohin Advances Autonomous AI With Elza A.I.
Velaris Markets launches dual brokerage and prop trading model under one brand
inCruises extiende su racha ganadora de Premios Magellan con dos reconocimientos en 2026
inCruises、2026年に2つの受賞により、Magellan賞の連続受賞記録を更新
Vivex Biologics' VIA Disc® NP Meets Primary Endpoint in Pivotal, Sham-Controlled ASCEND Trial Published in Journal of Clinical Medicine
Nacuity Pharmaceuticals Announces First Patient Dosed in Global Confirmatory Phase 3 Trial of NPI-001 (N-acetylcysteine amide) Tablets for the Treatment of Retinitis Pigmentosa Associated with Usher Syndrome
Critical Metals Corp. Confirms Option Scheme Consideration for European Lithium Acquisition
Avaí Bio and Austrianova Announce Publication in Frontiers in Aging Journal Highlighting Novel Cell Encapsulation-Based Approach to Sustained Klotho Delivery
FEMSA Anuncia Resultados del Tercer Trimestre 2026
FEMSA Announces Third Quarter 2026 Results
SELLAS Life Sciences Reaches 80th Event in Phase 3 REGAL Trial of Galinpepimut-S (GPS) in Acute Myeloid Leukemia

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

LATAM News Online

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.